PURPOSE: To estimate 4-year incidence and progression of early and advanced age-related macular degeneration (AMD). DESIGN: Population-based cohort study. METHODS: A comprehensive ophthalmologic examination including stereoscopic fundus photography was performed on adult Latinos at baseline and follow-up. Photographs were graded using a modified Wisconsin Age-Related Maculopathy Grading System. For estimations of incidence and progression of AMD, the Age Related Eye Disease Study Scale was used. Main outcome measures are incidence and progression of early AMD (drusen type, drusen size, and retinal pigmentary abnormalities) and advanced AMD (exudative AMD and geographic atrophy). RESULTS: A total of 4658 of 6100 subjects (76%) completed the follow-up examination. The 4-year incidence of early AMD was 7.5% (95% CI: 6.7, 8.4) and advanced AMD was 0.2% (95% CI: 0.1, 0.4). Progression of any AMD occurred in 9.2% (95% CI: 8.3, 10.1) of at-risk participants. Incidence and progression increased with age. Incidence of early AMD in the second eye (11.2%) was higher than incidence in the first eye (6.9%). Baseline presence of soft indistinct large drusen >or=250 microm in diameter was more likely to predict the 4-year incidence of pigmentary abnormalities, geographic atrophy, and exudative AMD than smaller or hard or soft distinct drusen. CONCLUSIONS: Age-specific incidence and progression of AMD in Latinos are lower than in non-Hispanic whites. While incident early AMD is more often unilateral, the risk of its development in the second is higher than in the first eye. Older people and those with soft indistinct large drusen had a higher risk of developing advanced AMD compared to those who were younger and did not have soft indistinct large drusen. Copyright 2010 Elsevier Inc. All rights reserved.
PURPOSE: To estimate 4-year incidence and progression of early and advanced age-related macular degeneration (AMD). DESIGN: Population-based cohort study. METHODS: A comprehensive ophthalmologic examination including stereoscopic fundus photography was performed on adult Latinos at baseline and follow-up. Photographs were graded using a modified Wisconsin Age-Related Maculopathy Grading System. For estimations of incidence and progression of AMD, the Age Related Eye Disease Study Scale was used. Main outcome measures are incidence and progression of early AMD (drusen type, drusen size, and retinal pigmentary abnormalities) and advanced AMD (exudative AMD and geographic atrophy). RESULTS: A total of 4658 of 6100 subjects (76%) completed the follow-up examination. The 4-year incidence of early AMD was 7.5% (95% CI: 6.7, 8.4) and advanced AMD was 0.2% (95% CI: 0.1, 0.4). Progression of any AMD occurred in 9.2% (95% CI: 8.3, 10.1) of at-risk participants. Incidence and progression increased with age. Incidence of early AMD in the second eye (11.2%) was higher than incidence in the first eye (6.9%). Baseline presence of soft indistinct large drusen >or=250 microm in diameter was more likely to predict the 4-year incidence of pigmentary abnormalities, geographic atrophy, and exudative AMD than smaller or hard or soft distinct drusen. CONCLUSIONS: Age-specific incidence and progression of AMD in Latinos are lower than in non-Hispanic whites. While incident early AMD is more often unilateral, the risk of its development in the second is higher than in the first eye. Older people and those with soft indistinct large drusen had a higher risk of developing advanced AMD compared to those who were younger and did not have soft indistinct large drusen. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Tien Y Wong; Tien Wong; Usha Chakravarthy; Ronald Klein; Paul Mitchell; Gergana Zlateva; Ronald Buggage; Kyle Fahrbach; Corey Probst; Isabella Sledge Journal: Ophthalmology Date: 2007-08-06 Impact factor: 12.079
Authors: Matthew D Davis; Ronald E Gangnon; Li-Yin Lee; Larry D Hubbard; Barbara E K Klein; Ronald Klein; Frederick L Ferris; Susan B Bressler; Roy C Milton Journal: Arch Ophthalmol Date: 2005-11
Authors: Frederick L Ferris; Matthew D Davis; Traci E Clemons; Li-Yin Lee; Emily Y Chew; Anne S Lindblad; Roy C Milton; Susan B Bressler; Ronald Klein Journal: Arch Ophthalmol Date: 2005-11
Authors: C C Klaver; J J Assink; R van Leeuwen; R C Wolfs; J R Vingerling; T Stijnen; A Hofman; P T de Jong Journal: Invest Ophthalmol Vis Sci Date: 2001-09 Impact factor: 4.799
Authors: Corina J Shtir; Paul Marjoram; Stanley Azen; David V Conti; Loic Le Marchand; Christopher A Haiman; Rohit Varma Journal: BMC Genet Date: 2009-11-10 Impact factor: 2.797
Authors: Farzana Choudhury; Rohit Varma; Roberta McKean-Cowdin; Ronald Klein; Stanley P Azen Journal: Am J Ophthalmol Date: 2011-06-16 Impact factor: 5.258
Authors: Diana E Fisher; Barbara E K Klein; Tien Y Wong; Jerome I Rotter; Xiaohui Li; Sandi Shrager; Gregory L Burke; Ronald Klein; Mary Frances Cotch Journal: Ophthalmology Date: 2016-02-16 Impact factor: 12.079
Authors: Andrew Bastawrous; Philip I Burgess; Abdull M Mahdi; Fatima Kyari; Matthew J Burton; Hannah Kuper Journal: Trop Med Int Health Date: 2014-01-31 Impact factor: 2.622